$647 Million is the total value of SHANDA ASSET MANAGEMENT HOLDINGS Ltd's 52 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LC | LENDINGCLUB CORP | $370,717,000 | +8.3% | 97,814,405 | 0.0% | 57.29% | +2.0% | |
| CYH | COMMUNITY HEALTH SYS INC NEW | $91,248,000 | -16.2% | 27,484,473 | 0.0% | 14.10% | -21.0% | |
| KKR | KKR & CO L P DELcl a | $34,743,000 | +22.4% | 1,398,100 | 0.0% | 5.37% | +15.3% | |
| KN | KNOWLES CORP | $5,564,000 | +21.5% | 363,653 | 0.0% | 0.86% | +14.5% | |
| KMI | KINDER MORGAN INC DEL | $4,585,000 | +17.3% | 259,500 | 0.0% | 0.71% | +10.6% | |
| EQM | EQT MIDSTREAM PARTNERS LPunit ltd partn | $4,571,000 | -12.6% | 88,600 | 0.0% | 0.71% | -17.7% | |
| TRGP | TARGA RES CORP | $3,608,000 | +12.5% | 72,900 | 0.0% | 0.56% | +6.1% | |
| ENB | ENBRIDGE INC | $2,559,000 | +13.4% | 71,700 | 0.0% | 0.40% | +6.8% | |
| BPL | BUCKEYE PARTNERS L Punit ltd partn | $2,246,000 | -6.0% | 63,900 | 0.0% | 0.35% | -11.5% | |
| XOM | EXXON MOBIL CORP | $1,802,000 | +10.9% | 21,785 | 0.0% | 0.28% | +4.1% | |
| TCP | TC PIPELINES LP | $1,487,000 | -25.2% | 57,300 | 0.0% | 0.23% | -29.4% | |
| AVB | AVALONBAY CMNTYS INC | $1,075,000 | +4.5% | 6,256 | 0.0% | 0.17% | -1.8% | |
| CARA | CARA THERAPEUTICS INC | $1,053,000 | +54.6% | 54,984 | 0.0% | 0.16% | +45.5% | |
| PTCT | PTC THERAPEUTICS INC | $1,023,000 | +24.6% | 30,332 | 0.0% | 0.16% | +17.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $982,000 | +18.5% | 10,000 | 0.0% | 0.15% | +11.8% | |
| VNDA | VANDA PHARMACEUTICALS INC | $853,000 | +13.0% | 44,787 | 0.0% | 0.13% | +6.5% | |
| FNSR | FINISAR CORP | $810,000 | +13.9% | 45,000 | 0.0% | 0.12% | +6.8% | |
| ACOR | ACORDA THERAPEUTICS INC | $745,000 | +21.3% | 25,957 | 0.0% | 0.12% | +13.9% | |
| VNO | VORNADO RLTY TRsh ben int | $739,000 | +9.8% | 10,000 | 0.0% | 0.11% | +3.6% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $623,000 | -16.2% | 35,278 | 0.0% | 0.10% | -21.3% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $599,000 | +30.8% | 10,000 | 0.0% | 0.09% | +24.0% | |
| ZGNX | ZOGENIX INC | $442,000 | +10.2% | 10,000 | 0.0% | 0.07% | +3.0% | |
| MRNS | MARINUS PHARMACEUTICALS INC | $71,000 | +86.8% | 10,000 | 0.0% | 0.01% | +83.3% | |
| AXSM | AXSOME THERAPEUTICS INC | $64,000 | +30.6% | 19,958 | 0.0% | 0.01% | +25.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALPHABET INC | 23 | Q2 2024 | 33.7% |
| COMMUNITY HEALTH SYS INC NEW | 20 | Q1 2021 | 28.1% |
| AMAZON COM INC | 19 | Q3 2023 | 20.0% |
| HERCULES TECH GROWTH CAP INC | 15 | Q4 2021 | 9.7% |
| LENDINGCLUB CORP | 14 | Q1 2019 | 61.1% |
| KINDER MORGAN INC DEL | 14 | Q1 2019 | 0.8% |
| INVESCO QQQ TR | 13 | Q2 2024 | 67.4% |
| TARGA RES CORP | 13 | Q1 2019 | 0.7% |
| MEDPACE HLDGS INC | 13 | Q4 2021 | 0.8% |
| IQVIA HLDGS INC | 13 | Q4 2021 | 0.7% |
View SHANDA ASSET MANAGEMENT HOLDINGS Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View SHANDA ASSET MANAGEMENT HOLDINGS Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.